The AEgis Technologies Group Announces the Release of acslXpress(r) Version 2 3

Released on = January 25, 2007, 6:42 am

Press Release Author = The AEgis Technologies Group

Industry = Pharmaceuticals

Press Release Summary = acslXpress M&S software facilitates in silico analysis
(ADMET) and allows users to conduct PK/PBPK/PD analysis without model development.
It provides full model execution and analysis capabilities by incorporating
pre-built models. Using models with point-and-click interfaces, the software is
suitable for production use. In addition, it can be combined with the acslXtreme
model development environment, giving users access to an enterprise-wide program
from discovery through clinical trials

Press Release Body = Huntsville, Alabama - January 25th, 2007. The AEgis
Technologies Group, Inc., a leading supplier of simulation software, training, and
engineering services to the international modeling and simulation community,
announces the release of version 2.3 of the acslXpress environment for execution and
analysis of simulations created using pre-built models. For analysts who only
require the ability to run and analyze simulations developed by others, acslXpress
provides all the advanced analytical capability of acslXtreme at a fraction of the
cost.

This latest version introduces an array of new features including out-of-the-box
support for parallel cluster/grid computing, advanced parameter estimation
capabilities such as Markov Chain Monte-Carlo analysis, database connectivity
support, and an assortment of utilities for model documentation and data
post-processing. This release additionally incorporates numerous performance and
stability improvements throughout the product.

acslXpress works seamlessly with the award-winning acslXtreme environment to provide
an integrated, end-to-end capability for model development, simulation execution,
and results analysis. In acslXtreme, models are specified using either familiar
block diagram notation, or code-based descriptions based on the CSL modeling
language. By default, all model representations are translated into C or FORTRAN
language source code for compilation and execution, ensuring the fastest possible
performance and support for extremely large or complex models. Open application
programming interfaces (APIs) are provided throughout the system to extend
acslXtreme functionality, allow the integration of custom or legacy code within
acslXtreme models, or to embed the generated simulation into end-user applications.
Model code reuse is supported through easily creatable user-defined libraries of
simulation blocks. acslXtreme provides a powerful simulation control scripting
language and mathematical analysis environment based on the popular M-File language.


Version 2.3 of acslXpress continues the tradition of its predecessor, ACSL®, which
was one of the first commercially available modeling and simulation tools designed
for simulating continuous systems. ACSL has been validated through more than 25
years of continuous use by the world\'s most demanding simulation professionals.

For additional information, or to request a free trial of acslXtreme and/or
acslXpress, please visit www.acslx.com, or contact AEgis at 1-800-647-ACSL.

About AEgis
The AEgis Technologies Group, Inc. provides next-generation modeling and simulation
(M&S) software for the pharmaceutical/risk assessment, industrial process,
automotive, and military/aerospace markets. AEgis supports its customers with
software, training, and consulting services throughout Europe, Asia, and The
Americas. AEgis corporate headquarters are located at 631 Discovery Drive,
Huntsville, AL 35806; Tel: 256-922-0802; Fax: 256-922-0904; Web: www.acslx.com.

acslXtreme® is a registered trademark of The AEgis Technologies Group, Inc.
acslXpressT is a trademark of The AEgis Technologies Group, Inc.


Web Site = http://www.acslx.com

Contact Details = The AEgis Technologies Group, Inc.
631 Discovery Drive
Huntsville, Alabama 35806
Phone: 800-647-ACSL
www.acslx.com
info@aegistg.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •